NCT05199636 is a NA clinical trial of Dragon fruit product in Blood Pressure, sponsored by Oxford Brookes University.

Who is sponsoring NCT05199636?

NCT05199636 is sponsored by Oxford Brookes University.

What drugs are being tested in NCT05199636?

Interventions in NCT05199636: Dragon fruit product.

What condition does NCT05199636 study?

NCT05199636 studies Blood Pressure, Glucose Intolerance.

Is NCT05199636 still recruiting?

NCT05199636 is currently completed. Last updated 6 September 2023.

Last reviewed 2023-09-06 · How we verify

NCT05199636

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Dragon Fruit Consumption in Individuals at Risk of Type 2 Diabetes

Completed NA Last updated 6 September 2023

What this trial tests

NA trial testing Dragon fruit product in Blood Pressure in 20 participants. Completed in 1 September 2023.

Timeline

20 January 2022

Primary endpoint
31 August 2023

1 September 2023

Quick facts

Lead sponsor	Oxford Brookes University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	20
Start date	20 January 2022
Primary completion	31 August 2023
Estimated completion	1 September 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

Dragon fruit product

Conditions studied

Blood Pressure — all drugs for Blood Pressure →
Glucose Intolerance — all drugs for Glucose Intolerance →

Sponsor

Oxford Brookes University

Who can join

Adults 18 to 50, any sex, with Blood Pressure or Glucose Intolerance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this project, an edible product based on dragon fruit will be tested to determine its effect on blood glucose levels and blood pressure in individuals at risk of type 2 diabetes. The effect of a product from dragon fruit on fasting plasma glucose and blood pressure will be assessed by a parallel study design with two groups and 16 participants in each one. Secondary outcomes such as inflammation biomarkers, lipid profile and oxidative stress markers also will be determined in blood samples.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of Frozen Red Dragon Fruit Consumption on Metabolic Markers in Healthy Subjects and Individuals at Risk of Type 2 Diabetes.
Flores-Verastegui MIM, Coe S, Tammam J, Almahjoubi H, et al · · 2025 · cited 1× · PMID 39940297 · DOI 10.3390/nu17030441

Verify or expand the search:

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting

Other Oxford Brookes University trials

Trials by the same sponsor.

NCT06159296 — Effect of Inhaled Hydroxy Gas on Long COVID Symptoms · NA · unknown
NCT05888584 — Improving Access and Recruitment to Clinical Trials for Lung Cancer Patients · NA · recruiting
NCT05780164 — Improving Access to Lung Cancer Clinical Trials · recruiting
NCT05839860 — Salt Intake, Hydration Status and Gastrointestinal Discomfort During Fasting · NA · completed
NCT05412654 — Potassium Supplementation to Reduce Blood Pressure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05199636 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oxford Brookes University
Last refreshed: 6 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05199636.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing